FASTigial
Recruiting
Who can enter
Children/adolescents whom will have surgery / had surgery of a tumor in the brain or brainstem
Age: 2 - 18 years old
Children/adolescents and parents who understand and speak Dutch
Goal
Goal
The goal of this study is to learn more about cerebellar mutism syndrome. Children and adolescents with this syndrome have problems with speaking or cannot speak anymore after surgery.
In the FASTigial study, we investigate factors that influence the onset and recovery of cerebellar mutism syndrome. We will examine clinical and MRI measures which predict the neuropsychological outcome in children with posterior fossa tumors. We will look into following factors:
MR imaging measures
Neuropsychological outcome
Background
Background
Around 25% of the children who undergo surgery for a tumor in the cerebellum or brainstem develops cerebellar mutism syndrome. These children can have problems with speaking, but they can also have problems with:
Precise movements of arms and legs
Eating and drinking
Being more irritable
The syndrome is usually temporary. Some children keep having problems with speaking and moving.
We know that this syndrome is caused by the surgery. However, the exact cause and how we can prevent this syndrome, is unknown.
In the European CMS study, we investigate cerebellar mutism syndrome. To gain further insight into this condition, the Princess Máxima Center has linked a research project to this study. This research is called: FASTigial. For this study, we collect data of patients whom will have surgery or had surgery of a tumor in the cerebellum or brainstem.
Data that we collect:
MR imaging
Neuropsychological outcome, for example the child’s attention and memory
Some children who participate in this study will develop cerebellar mutism syndrome and other children will not. We will compare these two groups. In this way, we can learn more about this syndrome and the factors that lead to the syndrome and its recovery. We also hope to improve treatment and to prevent this syndrome in the future.
This study will only collect data. The study does not impact treatment.
In order to participate in a study please refer to your/your child’s doctor. This study is only for children/adolescents and parents who understand and speak Dutch.
Last reviewed
Last reviewed
March 20, 2026
Study details
- Study details
Official title
FASTigial: Finding Anatomical SubsTrates of neuropsychological outcome in children with posterior fossa tumors (add-on project on the European CMS study)Cancer type
Tumor in the cerebellum
Tumor in the brainstem
Maximum number of patients
210 children and young adults, of whom 80 are expected to participate in the NetherlandsStart date
July 18, 2024Status
OpenLocal principal investigator
FASTigial: Dr. M.H. PartanenSponsor
Princess Máxima Center for Pediatric OncologyApproval
This study has been reviewed by an accredited medical research ethics committee. This committee has decided that it is justified to ask patients to participate in this study. More information can be found at: CCMO.Trial registry number
Registry ISRCTN: ISRCTN70465429
The above information is intended as a brief summary only and may not reflect the most up-to-date information. For full details and the current status of a protocol, physicians can contact the Princess Máxima Center directly.